Literature DB >> 33171402

Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment.

Marta Reina-Couto1, Joana Afonso2, Jorge Carvalho3, Luís Morgado4, Fernanda Aparecida Ronchi5, Ana Paula de Oliveira Leite5, Cláudia Camila Dias6, Dulce Elena Casarini5, Paulo Bettencourt7, António Albino-Teixeira2, Manuela Morato8, Teresa Sousa9.   

Abstract

We investigated oxidative stress and RAAS biomarkers, as well as their association, in chronic heart failure (CHF) patients on optimized medical therapy, stratified by disease severity or by renal function. Since vitamin D has been shown to attenuate RAAS activation and oxidative stress, we further evaluated the relationship between vitamin D, RAAS and oxidative stress in CHF patients with or without renal impairment. Sixty CHF outpatients were included and stratified by disease severity or by renal function. We quantified urinary hydrogen peroxide, plasma and urinary isoprostanes, plasma total antioxidant status, urinary angiotensinogen (intrarenal RAAS activation biomarker) and plasma angiotensinogen, plasma renin and aldosterone concentration, serum angiotensin-converting enzyme (ACE) activity, plasma angiotensin peptides, and serum total 25-hydroxyvitamin D (S-total 25(OH)D). Severe CHF patients had higher urinary isoprostanes (p = 0.002) and lower S-total 25(OH)D (p = 0.006) compared to mild-to-moderate patients, but no differences were observed for other redox or RAAS biomarkers. Patients with impaired renal function (iRF) had higher urinary angiotensinogen (p = 0.003) and lower S-total 25(OH)D (p = 0.028) compared to those with normal renal function (nRF), while no differences were observed for the remaining RAAS and redox parameters. Several positive correlations between oxidative stress and RAAS biomarkers were detected in iRF patients, while in patients with nRF these correlations were primarily inverse. In CHF-iRF patients, S-25(OD)D was inversely associated with urinary isoprostanes, which in turn were positively associated with plasma angiotensinogen and serum ACE. In conclusion, CHF patients with renal function impairment have increased intrarenal RAAS activation and lower vitamin D values and might benefit from the combination of RAAS blockers with vitamin D and/or antioxidants.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Cardiorenal syndrome; Oxidative stress; Renin-angiotensin-aldosterone system; Urinary angiotensinogen; Vitamin D

Year:  2020        PMID: 33171402     DOI: 10.1016/j.biopha.2020.110938

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

Review 1.  Bone Marrow Origin of Coronary Artery Diseases: The Impact of the Local Renin-Angiotensin System.

Authors:  Ugur Nadir Karakulak; Elifcan Aladag; Ibrahim Celalettin Haznedaroğlu
Journal:  Acta Cardiol Sin       Date:  2022-01       Impact factor: 2.672

2.  Efficacy and safety of sacubitril-valsartan in patients with heart failure: a systematic review and meta-analysis of randomized clinical trials: A PRISMA-compliant article.

Authors:  Jiezhong Lin; Jianyi Zhou; Guiting Xie; Jinguang Liu
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

3.  Lifestyle-Induced Redox-Sensitive Alterations: Cross-Talk among the RAAS, Antioxidant/Inflammatory Status, and Hypertension.

Authors:  Renáta Szabó; Denise Börzsei; Alexandra Hoffmann; Zelma Nadin Lesi; Rudolf Gesztelyi; Béla Juhász; Gábor J Szebeni; Jasmin Osman; Judith Sebestyén; Arnold Nagy; Sándor Szegedi; Csaba Varga; Anikó Pósa
Journal:  Oxid Med Cell Longev       Date:  2021-10-25       Impact factor: 6.543

4.  Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats.

Authors:  Li-Li Hong; Yan Zhao; Wei-Dong Chen; Chen-Yu Yang; Guo-Zhuan Li; Hong-Song Wang; Xiao-Yu Cheng
Journal:  Front Cardiovasc Med       Date:  2022-09-14

Review 5.  Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome.

Authors:  Kexin Ma; Weifang Gao; Huazhou Xu; Wenjie Liang; Guoping Ma
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2022-01-24       Impact factor: 1.636

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.